--- title: "REG: Revenue up 16.3%, profit up 13.8%, strong cash flow and acquisitions drive growth" type: "News" locale: "en" url: "https://longbridge.com/en/news/296712978.md" description: "Revenue grew 16.3% to $1.35bn, with underlying EBITDA up 9.7% and statutory net profit after tax up 13.8%. Major acquisitions and strong cash flow supported growth, while regulatory reforms and demographic trends underpin a positive outlook.Original document: Regis Healthcare Ltd. [REG] Annual Report — Aug. 24 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source." datetime: "2026-08-23T23:21:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296712978.md) - [en](https://longbridge.com/en/news/296712978.md) - [zh-HK](https://longbridge.com/zh-HK/news/296712978.md) generator: "portal-rs" --- # REG: Revenue up 16.3%, profit up 13.8%, strong cash flow and acquisitions drive growth Revenue grew 16.3% to $1.35bn, with underlying EBITDA up 9.7% and statutory net profit after tax up 13.8%. Major acquisitions and strong cash flow supported growth, while regulatory reforms and demographic trends underpin a positive outlook. Original document: Regis Healthcare Ltd. \[REG\] Annual Report — Aug. 24 2026 **Disclaimer** This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source. ### Related Stocks - [REG.AU](https://longbridge.com/en/quote/REG.AU.md) ## Related News & Research - [RBC Capital downgrades Regis Healthcare Ltd. (REG) to a Hold](https://longbridge.com/en/news/297977637.md) - [Ord Minnett downgrades Regis Healthcare Ltd. (REG) to a Hold](https://longbridge.com/en/news/297843353.md) - [Baseten acquires Tekedia Capital portfolio company Blaxel](https://longbridge.com/en/news/298617788.md) - [Labcorp buys MLM Medical Labs](https://longbridge.com/en/news/298332531.md) - [TML Tender Offer - Publication of the Offer Document](https://longbridge.com/en/news/298070476.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**